. | . | .

Altratech Home2024-08-20T12:15:25+00:00

Altratech has developed and patented a fundamentally novel process to detect and quantify DNA, RNA, Antibody, and Antigen molecular targets. The process replaces the need for time consuming ‘biological amplification’ required for optical read-outs, with almost instant ‘electronic signal amplification’ and a digital read-out. This will enable a new generation of portable diagnostic products that have the simplicity of lateral flow tests and the performance of a laboratory PCR test.

Learn More

Next Generation Molecular Detection

Discover Altratech

This novel digital diagnostic technology enables robust, straightforward and flexible molecular diagnostics in any environment.

Next Generation Molecular Detection

Discover Altratech

About Altratech

Altratech is a team of twenty scientists and engineers, including nine PhDs, from cross-functional backgrounds of molecular biology, organic and synthetic chemistry, microfluidics, engineering and CMOS semiconductor technologies. With over 200 years of combined experience, our vision is to create portable high-performance diagnostics which will enable the next generation of decentralised connected healthcare and wellbeing.

Learn More

At Altratech, our mission is to enable next generation molecular detection.

This exciting technology enables robust, straightforward and flexible molecular diagnostics in any environment.

Assay animation

In the News

Altratech awarded up to €10.5M by EIC Accelerator

1 Oct 2024:   Altratech awarded up to €10.5M grant+equity support by EIC Accelerator: .... EIC Accelerator 2024 full awardee list.... (Altratech's submission preparation assisted by MyEUConsulting SPRL).

More Stories

Our Investors

Our Investors

Go to Top